Lipid-based nanocarriers for CNS-targeted drug delivery.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Recent Patents on CNS Drug Discovery

• Publication date

  2012-03-31

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.2174/157488912798842241PMID 22283231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liposomes

  2012cited by this paper
• Drug transport to brain with targeted liposomes

  2011cited by this paper
• Barriers to Non-Viral Vector-Mediated Gene Delivery in the Nervous System

  2011cited by this paper
• The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy.

  2011cited by this paper
• Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues.

  2011cited by this paper
• Neurotherapeutic applications of nanoparticles in Alzheimer's disease.

  2011cited by this paper
• Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model.

  2011cited by this paper
• Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide.

  2011cited by this paper
• Advances in the treatment of neurodegenerative disorders employing nanotechnology

  2010cited by this paper
• Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations.

  2010cited by this paper
• Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging

  2010cited by this paper
• Tf-lipoplex-mediated c-Jun silencing improves neuronal survival following excitotoxic damage in vivo.

  2010cited by this paper
• Strategy for effective brain drug delivery.

  2010cited by this paper
• Effective stabilization and delivery of siRNA: reversible siRNA-phospholipid conjugate in nanosized mixed polymeric micelles.

  2010cited by this paper
• Nanoparticle-Mediated Brain-Specific Drug Delivery, Imaging, and Diagnosis

  2010cited by this paper
• Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.

  2009cited by this paper
• Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His.

  2009cited by this paper
• Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting.

  2009cited by this paper
• Lipid nanoparticles for parenteral delivery of actives.

  2009cited by this paper
• Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting.

  2009cited by this paper
• New strategies to deliver anticancer drugs to brain tumors

  2009cited by this paper
• Lipid nanocapsules: a new platform for nanomedicine.

  2009cited by this paper
• Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience

  2009cited by this paper
• The encapsulation of DNA molecules within biomimetic lipid nanocapsules.

  2009cited by this paper
• Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.

  2009cited by this paper
• Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery.

  2009cited by this paper
• Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.

  2009cited by this paper
• Targeting glioma cells in vitro with ascorbate-conjugated pharmaceutical nanocarriers.

  2009cited by this paper
• Nanoparticles for direct nose-to-brain delivery of drugs.

  2009cited by this paper
• Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis.

  2009cited by this paper
• Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles

  2008cited by this paper
• Detection of isolated cerebrovascular β‐amyloid with pittsburgh compound B

  2008cited by this paper
• Physiology and pharmacological role of the blood-brain barrier.

  2008cited by this paper
• Drug targeting to the brain

  2008cited by this paper
• Inequalities in healthy life years in the 25 countries of the European Union in 2005: a cross-national meta-regression analysis.

  2008cited by this paper
• A study of rivastigmine liposomes for delivery into the brain through intranasal route

  2008cited by this paper
• From nose to brain: understanding transport capacity and transport rate of drugs

  2008cited by this paper
• Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes.

  2008cited by this paper
• Brain targeting using novel lipid nanovectors.

  2008cited by this paper
• Discovery of ADDL--targeting small molecule drugs for Alzheimer's disease.

  2007cited by this paper
• Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain.

  2007cited by this paper
• Liposomal drug delivery systems: an update review.

  2007cited by this paper
• Blood-brain barrier delivery.

  2007cited by this paper
• Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments.

  2007cited by this paper
• Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery

  2007cited by this paper
• Humanization of anti‐human insulin receptor antibody for drug targeting across the human blood–brain barrier

  2007cited by this paper
• The role of amyloid β peptide 42 in Alzheimer's disease

  2007cited by this paper
• Decreased circulation time offsets increased efficacy of PEGylated nanocarriers targeting folate receptors of glioma

  2007cited by this paper
• A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes.

  2007cited by this paper
• Micellar Nanocarriers: Pharmaceutical Perspectives

  2006cited by this paper
• Nanotechnology: Intelligent Design to Treat Complex Disease

  2006cited by this paper
• Lipid‐Based Parenteral Drug Delivery Systems: Biological Implications

  2006cited by this paper
• PEGylated phospholipid nanomicelles interact with beta-amyloid((1-42)) and mitigate its beta-sheet formation, aggregation and neurotoxicity in vitro.

  2006cited by this paper
• SP1049C as first-line therapy in advanced (inoperable or metastatic) adenocarcinoma of the oesophagus: A phase II window study.

  2006cited by this paper
• Albumin-bound paclitaxel: a next-generation taxane

  2006cited by this paper
• Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain

  2006cited by this paper
• Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

  2006cited by this paper
• Pros and Cons of the Liposome Platform in Cancer Drug Targeting

  2006cited by this paper
• A review of nanocarrier-based CNS delivery systems.

  2006cited by this paper
• Hyperthermia mediated liposomal drug delivery

  2006cited by this paper
• Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a ‘Trojan horse’

  2006cited by this paper
• [Micelle carrier system in clinical trial].

  2006cited by this paper
• Polymeric micelles for drug delivery

  2006cited by this paper
• Recent advances with liposomes as pharmaceutical carriers

  2005cited by this paper
• Lipid-core micelles for targeted drug delivery.

  2005cited by this paper
• Polyethylene Glycol (PEG) Modified 99mTc-HMPAOLiposome for Improving Blood Circulation and Biodistribution: The Effect of the Extent of PEGylation

  2005cited by this paper
• The blood-brain barrier: Bottleneck in brain drug development

  2005cited by this paper
• Targeting of daunomycin using biotinylated immunoliposomes: Pharmacokinetics, tissue distribution and in vitro pharmacological effects

  2005cited by this paper
• Block copolymer micelles: preparation, characterization and application in drug delivery.

  2005cited by this paper
• Drug Delivery Systems: Entering the Mainstream

  2004cited by this paper
• Coupling of Metal Containing Homing Devices to Liposomes via a Maleimide Linker: Use of TCEP to Stabilize Thiol-groups without Scavenging Metals

  2004cited by this paper
• Paclitaxel nanoparticles for the potential treatment of brain tumors.

  2004cited by this paper
• Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.

  2004cited by this paper
• Improving lipoplex-mediated gene transfer into C6 glioma cells and primary neurons.

  2004cited by this paper
• Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

  2004cited by this paper
• Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer

  2004cited by this paper
• Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.

  2004cited by this paper
• Enhanced Delivery of Octreotide to the Brain via Transnasal Iontophoretic Administration

  2004cited by this paper
• Intravenous Nonviral Gene Therapy Causes Normalization of Striatal Tyrosine Hydroxylase and Reversal of Motor Impairment in Experimental Parkinsonism

  2003cited by this paper
• Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles

  2003cited by this paper
• Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs

  2003cited by this paper
• Pharmacokinetics of Pegylated Liposomal Doxorubicin

  2003cited by this paper
• Morphology and molecular properties of cellular components of normal cerebral vessels.

  2003cited by this paper
• Novel Therapeutic Approach for the Treatment of Alzheimer's Disease by Peripheral Administration of Agents with an Affinity to β-Amyloid

  2003cited by this paper
• A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers

  2002cited by this paper
• Optimizing pH-responsive Polymeric Micelles for Drug Delivery in a Cancer Photodynamic Therapy Model

  2002cited by this paper
• AC-magnetic field controlled drug release from magnetoliposomes: design of a method for site-specific chemotherapy.

  2002cited by this paper
• Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification.

  2001cited by this paper
• Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles.

  2001cited by this paper
• Structure and design of polymeric surfactant-based drug delivery systems.

  2001cited by this paper
• TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors

  2001cited by this paper
• Biodegradable polymeric nanoparticles as drug delivery devices.

  2001cited by this paper
• p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups.

  2001cited by this paper
• Phototriggering of liposomal drug delivery systems.

  2001cited by this paper
• Brain-specific expression of an exogenous gene after i.v. administration

  2001cited by this paper
• Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin.

  2001cited by this paper
• Nanoparticulate systems for brain delivery of drugs.

  2001cited by this paper
• The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors.

  2001cited by this paper
• Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size.

  2000cited by this paper
• Lipid-DNA and lipid-polyelectrolyte mesophases: structure and exchange kinetics.

  2000cited by this paper

• Lipid-based nanostructures in targeted management of neurological disorders: a comprehensive review.

  2025cites this paper
• Engineering Liposomes for Neurodegenerative Diseases: Targeted Delivery and Regenerative Potential

  2025cites this paper
• Precision targeting of the CNS: recent progress in brain-directed nanodrug delivery

  2025influential citation
• Exploring novel roles of lipid droplets and lipid metabolism in regulating inflammation and blood–brain barrier function in neurological diseases

  2025cites this paper
• Liposomal Drug Delivery for Neurological Disorders: Advances and Challenges.

  2024cites this paper
• Nanoparticle-Based Therapies for Management of Subarachnoid Hemorrhage, Neurotrauma, and Stroke

  2024cites this paper
• Immuno-Nanotherapeutics Approach for the Treatment and Management of Alzheimer’s Disease

  2024cites this paper
• The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers

  2023cites this paper
• Potential of Lipid-Based Nanocarriers against Two Major Barriers to Drug Delivery—Skin and Blood–Brain Barrier

  2023cites this paper
• Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date

  2022cites this paper
• Comparison of Tau and Amyloid-β Targeted Immunotherapy Nanoparticles for Alzheimer’s Disease

  2022cites this paper
• Emerging nanoformulations for drug targeting to brain through intranasal delivery: A comprehensive review

  2022cites this paper
• Temozolomide: an Overview of Biological Properties, Drug Delivery Nanosystems, and Analytical Methods.

  2022cites this paper
• Potential nanotherapeutic strategies for perioperative stroke

  2022cites this paper
• Brain targeting of agomelatine egg lecithin based chitosan coated nanoemulsion

  2021cites this paper
• AN OVERVIEW ON BRAIN TARGETED DRUG DELIVERY SYSTEM

  2021cites this paper
• Vesicular carriers for direct nose-to-brain drug delivery

  2021cites this paper
• Nanomedicine: A Promising Way to Manage Alzheimer’s Disease

  2021cites this paper
• Nanomaterial synthesis, an enabler of amyloidosis inhibition against human diseases.

  2020cites this paper
• Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems

  2020influential citation
• New Nanomaterials and Techniques for Tumor-targeted Systems

  2020cites this paper
• Lipid-Based Tumor-targeted Systems

  2020cites this paper
• Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges.

  2019cites this paper
• Liposome-based targeted delivery of anticancer drugs for effective therapy of brain tumors

  2019cites this paper
• Nanopharmaceuticals: A Boon to the Brain-Targeted Drug Delivery

  2019cites this paper
• Biologically-Derived Nanomaterials for Targeted Therapeutic Delivery to the Brain

  2018cites this paper
• Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease

  2018cites this paper
• Sophorolipid Butyl Ester Diacetate Does Not Affect Macrophage Polarization but Enhances Astrocytic Glial Fibrillary Acidic Protein Expression at Micromolar Concentrations in Vitro.

  2017cites this paper
• Effects of chitosan-coated lipid-core nanocapsules on bovine sperm cells.

  2017cites this paper
• CNS Drug Delivery for Diseases Eradication: An Overview

  2017cites this paper
• Nanoparticulate strategies for the treatment of polyglutamine diseases by halting the protein aggregation process†

  2017cites this paper
• Advances in Personalized Nanotherapeutics

  2017cites this paper
• Diagnosis and Drug Delivery to the Brain

  2017cites this paper
• Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.

  2016influential citation
• Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier

  2016cites this paper
• [Function, aging and dysfunction of blood-brain barrier. Crossing the barrier].

  2016cites this paper
• Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier

  2016cites this paper
• In Vitro Modulation of TrkB Receptor Signaling upon Sequential Delivery of Curcumin-DHA Loaded Carriers Towards Promoting Neuronal Survival

  2016cites this paper
• A vér–agy gát működése, öregedése és diszfunkciója. Átjutás a barrieren

  2016cites this paper
• Advances in Neurotherapeutic Delivery Technologies

  2015cites this paper
• Nanomedicine concepts in the general medical curriculum: initiating a discussion

  2015cites this paper
• Pharmaceutical and biomedical applications of lipid-based nanocarriers.

  2014cites this paper
• Nanomedicines for nervous system diseases

  2014cites this paper
• Humanized Mice as a Platform for the Development of Long-Acting Nanoformulated Antiretroviral Therapy

  2014cites this paper
• Cell-Based Drug Delivery for Improving Antiretroviral Therapeutic Outcomes

  2014cites this paper
• Etiology and Pathogenesis of Late-Onset Alzheimer’s Disease

  2014cites this paper
• Heart-targeted nanoscale drug delivery systems.

  2014cites this paper
• Therapeutic approaches for lysosomal storage diseases: a patent update.

  2013cites this paper
• Functionalizable Amine-based Polymer Nanoparticles.

  2013cites this paper
• Liposomes pour distribution in vivo

  2013cites this paper
• Small RNA drugs for prion disease: a new frontier

  2013cites this paper
• Treatment of cerebral ischemia‐reperfusion injury with PEGylated liposomes encapsulating FK506

  2013cites this paper
• Clinical Pharmacokinetics of Antibacterials in Cerebrospinal Fluid

  2013cites this paper
• Methodological Issues : Do Membrane Rafts Exist ?

  2012cites this paper
• Advances in delivery systems and routes for local anaesthetics

  2012cites this paper
• Impacts of blood-brain barrier in drug delivery and targeting of brain tumors.

  2012cites this paper